These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2425303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 5. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T, Satoh N, Sakuma I, Matsumura T, Kisara K, Arai Y, Kinemuchi H.
    Life Sci; 1987 Mar 30; 40(13):1309-18. PubMed ID: 2436017
    [Abstract] [Full Text] [Related]

  • 6. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
    Rollema H, De Vries JB, Westerink BH, Van Putten FM, Horn AS.
    Eur J Pharmacol; 1986 Dec 02; 132(1):65-9. PubMed ID: 3102260
    [Abstract] [Full Text] [Related]

  • 7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ, Heavens RP, Richards SJ, Beresford IJ, Hall MD.
    Neuroscience; 1988 Oct 02; 27(1):117-28. PubMed ID: 3264391
    [Abstract] [Full Text] [Related]

  • 8. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 9. The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
    Bradbury AJ, Costall B, Jenner PG, Kelly ME, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Jul 31; 58(2):177-81. PubMed ID: 2413398
    [Abstract] [Full Text] [Related]

  • 10. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM, Arora PK, Iacofano LA, Harik SI.
    Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical changes caused by the infusion into the substantia nigra of the rat of MPTP and related compounds which antagonise dihydropteridine reductase.
    Bradbury AJ, Brossi A, Costall B, Domeney AM, Gessner W, Naylor RJ.
    Neuropharmacology; 1986 Jun 13; 25(6):583-6. PubMed ID: 3489197
    [Abstract] [Full Text] [Related]

  • 13. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1986 Jun 13; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3343-7. PubMed ID: 3135812
    [Abstract] [Full Text] [Related]

  • 15. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ, Whittington PE, Audsley AR.
    Brain Res; 1986 Dec 10; 399(2):339-45. PubMed ID: 2435361
    [Abstract] [Full Text] [Related]

  • 16. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
    Chiueh CC, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ.
    Eur J Pharmacol; 1984 Apr 20; 100(2):189-94. PubMed ID: 6203759
    [Abstract] [Full Text] [Related]

  • 17. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.
    Espino A, Cutillas B, Tortosa A, Ferrer I, Bartrons R, Ambrosio S.
    Brain Res; 1995 Oct 16; 695(2):151-7. PubMed ID: 8556325
    [Abstract] [Full Text] [Related]

  • 18. Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sirinathsinghji DJ.
    Brain Res; 1985 Jul 29; 339(2):366-70. PubMed ID: 3928091
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.